Search results

1. AbbVie gets a cMet niche

   … in high cMet expressers at doses ≥2.4mg/kg); data due at ASCO 2025 in EGFRm non-sq NSCLC Notes: …

   
    

   Madeleine Armstrong
    
   - 05/19/2025 - 10:52

2. ASCO 2025 preview – late-breakers in focus

   ASCO 2025 preview – late-breakers in focus … the morning of their presentations.   Selected ASCO 2025 late-breakers Project Company/ies …

   
    

   Jacob Plieth
    
   - 04/28/2025 - 14:08